Detalhe da pesquisa
1.
Massive genomic rearrangement acquired in a single catastrophic event during cancer development.
Cell
; 144(1): 27-40, 2011 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21215367
2.
Risk Factors Associated with PTLD Related Mortality in Adult Multivisceral Transplant Recipients - A Single Centre Cohort Study.
Chirurgia (Bucur)
; 119(1): 5-20, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38465712
3.
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(12): 1423-1433, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944541
4.
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing.
Am J Hematol
; 98(5): 750-759, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866925
5.
Incidence and outcomes of post-transplant lymphoproliferative disease after 5365 solid-organ transplants over a 20-year period at two UK transplant centres.
Br J Haematol
; 197(3): 310-319, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235680
6.
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline.
Br J Haematol
; 197(5): 558-572, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191541
7.
Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis.
Haematologica
; 107(2): 489-499, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567811
8.
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients.
Br J Haematol
; 193(2): 290-298, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620106
9.
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
Lancet
; 395(10232): 1278-1291, 2020 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32305093
10.
Transverse Leukonychia (Mees' Lines).
N Engl J Med
; 389(22): e48, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009615
11.
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
Ann Hematol
; 100(4): 1049-1058, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641019
12.
Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
J Pathol
; 250(3): 346-357, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31859368
13.
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma.
Future Oncol
; 17(11): 1295-1310, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528286
14.
Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma Identified in a Breast Implant Capsule: A New Breast Implant-Associated Lymphoma?
Ann Plast Surg
; 86(4): 383-386, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720919
15.
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study.
Am J Hematol
; 95(4): 362-371, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31868245
16.
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
Br J Haematol
; 185(4): 656-669, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768675
17.
Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
Blood
; 127(4): 436-48, 2016 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26508782
18.
Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
Blood
; 128(19): 2319-2326, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27528712
19.
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib.
Blood
; 127(23): 2847-55, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26941398
20.
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.
Haematologica
; 103(7): 1209-1217, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674504